User blogs
Tag Search
Fact.MR has published a research report on global Antibodies
market assessing the period between 2017 to 2022. Antibodies (Ab) are
also known as immunoglobulin (Ig). These are the large, Y-shaped protein that
are produced primarily by plasma cells present in the blood in response to
pathogens such as viruses and bacteria. Antibodies are capable of identifying
unique molecules with harmful agents. Antibodies are used in various
therapeutic areas as well as in diagnostics of disease indications such as
rheumatoid arthritis, non-Hodgkin lymphoma, psoriasis, macular degeneration,
asthma, Crohn’s disease, and hypercholesterolemia.
With COVID Vaccines Development Underway and Other Prominent
Developments, Antibodies Market is Expected to Witness Fruitful Growth,
observes Fact.MR
Explore how Europe
region is performing for Antibodies Market: https://www.factmr.com/connectus/sample?flag=S&rep_id=194
Outbreak of COVID-19
to Provide Impetus to Market Growth
The overall competitive landscape of the global antibodies
market is a quite fragmented in nature. The companies in the market are
focusing on aggressive growth strategies such as mergers, takeovers, and
acquisition in order to stay ahead of the competition. Moreover, the companies
in the market are collaborating with notable research institutes and
establishments to develop cure for prolonged viral diseases. Case in point –
COVID-19 vaccine. Several companies operating in the market such as Abcam Plc,
A.M.S. Biotechnology (Europe) Limited, Bio-Rad Laboratories, Inc., Cell
Signaling Technology, Genscript Biotech Corporation, Sigma Aldrich Corp, Crown
Bioscience, Inc., Thermo Fisher Scientific, Inc. have started working on the
development of COVID-19 antibodies. The market is expected to witness a tough
competition in the coming years of the forecast period ranging from 2017 to
2022. Currently, the vaccine developed by AstraZeneca and Pfizer have received
emergency approval for distribution. Such developments are likely to fuel the
development of the global market in the near future.
Explore Fact.MR's
lucid coverage of the Healthcare landscape
There are multiple factors that are expected to help the
overall development of the global antibodies market. One of the driving factor
for the market has been the prevalence of chronic ailments and disorders across
the globe. With multiple diseases such as different types of cancer, chronic heart
disorders, diabetes, and frequent outbreak of infectious diseases, there are
several growth opportunities for the global antibodies market. With such
prominent factors driving the market growth, the Global antibodies is expected
to reach a valuation worth US$1,091 Mn by the end of the forecast period
ranging from 2017 to 2022. The primary antibodies segment is projected to
create an absolute growth opportunity of US$ 168.4 Mn between 2017 and 2022.
Contact Information
Fact.MR
11140 Rockville Pike
Suite 400
11140
United States
Phone: 6282511583
Find More: https://www.prnob.com/release/show/antibodies-market-will-cross/44555